AVAKADO EVENTS PREVIEW
The Peptide Conference 2012 programme: all the papers at a glance
Tuesday, April 17, 2012
Morning Session 1 Peptide Structure & Applications 09:00-09:40
Lead finding for peptide therapeutics Dr Thomas Vorherr – Director Peptide Discovery, Novartis Pharma
09:40-10:20
Enhanced tools for the discovery, development and manufacture of peptides and proteins Dr David Moody – CEO, TechnoPep Ltd
10:20-11.00 Coffee Break
Morning Session 2 Peptide Structure & Applications
11:00-11:40
Flax cyclic peptides: profiling, isolation, characterisation and
Dr Martin Reaney – Department of Plant Sciences, University of Saskatchewan, Canada
11:40-12:20
Flax peptides as an analytical tool Pramodkumar Jadhav, MSc – Department of Food and Bioproduct Sciences, University of Saskatchewan, Canada
12:20-13:30 Lunch
Afternoon Session 1 Peptide Synthesis and Manufacture Chaired by Dr Don Wellings, Chief Executive Officer, SpheriTech Ltd
13:30-14:10
Manufacturing of peptide APIs: latest developments in chemistry and technology
Dr Ralph Schoenleber – Bachem AG 14:10-14:50
Innovation in process technology for high-quality and cost-effective peptide manufacturing Dr Mimoun Ayoub – Vice President Strategic Development, Peptisyntha
46 sp2 Inter-Active March/April 2012
14:50-15:30 Coffee Break
Afternoon Session 2 Peptide Synthesis and Manufacture Chaired by Dr Don Wellings
15:30-16:10
AJIPHASE® - A new approach for liquid phase peptide synthesis (LPPS) using soluble support anchors Dr Daisuke Takahashi – Section Chief, Synthesis Group, Research Institute for Bioscience Products and Fine Chemicals, Ajinomoto Co, Inc
16:10-16:50
New technologies for peptide manufacturing
Speaker tbc – Lonza Braine
16:50-17:30 Peptide mimetics as artificial blood group antigens
Robert Flower and Rhiannon McBean – Queensland University of Technology and the Australian Red Cross Blood Service; and Damien Heathcote – CSL Biosciences
18:00-20:00 Networking Reception
End of Day One 14:10-14:50
Day Two Wednesday, April 18, 2012
Morning Session 1 Peptide Synthesis and Manufacture 09:00-09:40
Carbon-14 labelled peptides: solid phase peptide synthesis, biotinylation and PEGylation
Dr Sean Kitson – Almac Sciences 09:40-10:20
New technology for solid phase peptide synthesis Dr Don Wellings – CEO, SpheriTech
10:20-11:00 Coffee Break
Enhanced peptide therapeutics through polymer conjugation Dr Sally Waterman – COO, PolyTherics Ltd
End of Conference
Contacts for further information
Contact avakado as follows:
Conference programme and delegate information: Tom Mulligan Tel: +44 (0)1403 220755 Email:
tom@avakado.eu
Exhibitor information: Mark Harrington Tel: +44 (0)1403 220753 Email:
mark@avakado.eu
Afternoon Session Peptide Therapeutics
13:30-14:10
Absence of amplification role of the protein KLH on antibody response generated by a MAP Staphyloccocus aureus enterotoxin A (SEA) peptide compared with the corresponding monomeric peptide
Dr Vincent Le Moigne – Université de Bretagne Occidentale (University of Western Brittany), France
12:20-13:30 Lunch
Morning Session 2 Peptide Therapeutics
11:00-11:40
Cell-penetrating peptide delivery of oligonucleotides for treatment of Duchenne muscular dystrophy Dr Michael Gait – MRC Programme Leader, University of Cambridge, UK
11:40-12:20
Biomimetic screening of class B G protein-coupled receptors Dr Felix Hausch – Research Group Leader, Chemical Genomics, Max- Planck-Institute of Psychiatry
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48